Skip to content

Ultrasound-guided Median Effective Volume of 0.3% Ropivacaine for Superior Trunk Block (STB) and Comparison of Effects with Interscalene Block (ISB)

Ultrasound-guided Median Effective Volume of 0.3% Ropivacaine for Superior Trunk Block (STB) and Comparison of Effects with Interscalene Block (ISB)

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2500103280
Enrollment
Unknown
Registered
2025-05-27
Start date
2025-06-01
Completion date
Unknown
Last updated
2025-06-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Shoulder surgery

Interventions

The group with ISB combined with general anesthesia:ISB combined with general anesthesia
The group with STB combined with general anesthesia:STB combined with general anesthesia

Sponsors

Wuhan Third Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 85 Years

Inclusion criteria

Inclusion criteria: Part 1: Adult patients of any gender, aged between 18 and 85 years, undergoing elective shoulder, proximal humerus, and clavicle surgery under general anesthesia combined with brachial plexus block. Part 2: Adult patients of any gender, aged between 18 and 85 years, undergoing elective shoulder arthroscopy under general anesthesia combined with brachial plexus block.

Exclusion criteria

Exclusion criteria: Chronic obstructive pulmonary disease (COPD), old cerebral infarction, comorbid diabetes or hypertension, transient ischemic attack (TIA), sleep apnea syndrome, allergy to study drugs, contraindications for nerve block, or unwillingness to participate in this study.

Design outcomes

Primary

MeasureTime frame
The median effective volume of 0.3% ropivacaine;Degree of sensory block;The mobility of the diaphragm;The reduction range of SpO2;The occurrence of Horner's sign;

Secondary

MeasureTime frame
Height;Weight;Sex;Age;Sleep quality;Analgesia score;The number of times the analgesic pump is pressed;The number of rescue times of the analgesic pump;Operation time;The dosage of sevoflurane;The usage situation of remifentanil;Nerve symptoms related to block;

Countries

China

Contacts

Public ContactHu Guangjun

Wuhan Third Hospital

jeanhu@163.com+86 189 0713 2861

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026